Anzu Special Acquisition Corp I (ANZUU)
Price:
7.09 USD
( + 0.49 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Apex Technology Acquisition Corporation
VALUE SCORE:
6
2nd position
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
The best
Horizon Kinetics SPAC Active ETF
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Anzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. The company was incorporated in 2020 and is based in Tampa, Florida.
NEWS
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination
newsfilecorp.com
2023-09-29 14:45:00NASDAQ to list Envoy Medical, developer of an FDA-designated breakthrough device for hearing loss - a novel fully implanted cochlear device White Bear Lake, Minnesota and Tampa, Florida--(Newsfile Corp. - September 29, 2023) - Anzu Special Acquisition Corp I (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) ("Anzu"), a special purpose acquisition company, and Envoy Medical Corporation ("Envoy" or "Envoy Medical"), a hearing health company, announced today the completion of their previously announced business combination ("the Business Combination"), resulting in Envoy becoming a publicly listed company. The combined company will operate under the name "Envoy Medical, Inc." and its Class A common stock and warrants are expected to commence trading on October 2, 2023, on the Nasdaq stock exchange under the new ticker symbols "COCH" and "COCHW", respectively.
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I
newsfilecorp.com
2023-09-28 12:00:00Envoy Medical Shareholders approve merger in special meeting held September 28th Anzu Special Acquisition Corp I announced shareholder approval for the merger September 27th Merger anticipated to close September 29 th with NASDAQ trading to begin October 2 nd under the ticker symbol COCH White Bear Lake, Minnesota--(Newsfile Corp. - September 28, 2023) - Envoy Medical® Corporation ("Envoy"), a hearing health company, today announced that the proposed merger with Anzu Special Acquisition Corp I (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) ("Anzu") was approved by a vote of Envoy Medical shareholders in a special meeting held September 28, 2023. The vote follows the announcement of approval by Anzu shareholders on September 27, 2023.
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
newsfilecorp.com
2023-09-19 16:05:00Board Reflects Expanded Resources as Company Readies for Nasdaq Listing White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2023) - Envoy Medical® Corporation ("Envoy"), a hearing health company, today announced the proposed slate of seven directors to be voted on during the special meeting of stockholders to be held by its merger partner, Anzu Special Acquisition Corp (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) ("Anzu"), which is expected to be held on September 27, 2023. The director nominees bring medical device industry, financial and equity capital markets expertise, including alumni of Abbott, Medtronic, Boston Scientific, Johnson & Johnson, PwC, and BCG.
Envoy Medical Appoints David R. Wells as Chief Financial Officer
newsfilecorp.com
2023-08-24 16:05:00Adds Experienced Financial and Equity Capital Markets Leader as Company Readies for Nasdaq Listing White Bear Lake, Minnesota--(Newsfile Corp. - August 24, 2023) - Envoy Medical® Corporation, a hearing health company, today announced the appointment of industry veteran David R. Wells as Chief Financial Officer.
CORRECTING and REPLACING Anzu Special Acquisition Corp I Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing April 22, 2021
businesswire.com
2021-04-21 22:51:00TAMPA, Fla.--(BUSINESS WIRE)---- $ANZU--First paragraph, first sentence of release should read: April 22, 2021 (instead of April 22, 2020). The updated release reads: ANZU SPECIAL ACQUISITION CORP I ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A COMMON STOCK AND WARRANTS, COMMENCING APRIL 22, 2021 Anzu Special Acquisition Corp I (NASDAQ: ANZUU) (the “Company”), a blank check company sponsored by Anzu SPAC GP I LLC, today announced that the holders of the Company's units sold in the Company's initial publi
No data to display
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination
newsfilecorp.com
2023-09-29 14:45:00NASDAQ to list Envoy Medical, developer of an FDA-designated breakthrough device for hearing loss - a novel fully implanted cochlear device White Bear Lake, Minnesota and Tampa, Florida--(Newsfile Corp. - September 29, 2023) - Anzu Special Acquisition Corp I (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) ("Anzu"), a special purpose acquisition company, and Envoy Medical Corporation ("Envoy" or "Envoy Medical"), a hearing health company, announced today the completion of their previously announced business combination ("the Business Combination"), resulting in Envoy becoming a publicly listed company. The combined company will operate under the name "Envoy Medical, Inc." and its Class A common stock and warrants are expected to commence trading on October 2, 2023, on the Nasdaq stock exchange under the new ticker symbols "COCH" and "COCHW", respectively.
Envoy Medical Announces Shareholder Approval on Proposed Merger with Anzu Special Acquisition Corp I
newsfilecorp.com
2023-09-28 12:00:00Envoy Medical Shareholders approve merger in special meeting held September 28th Anzu Special Acquisition Corp I announced shareholder approval for the merger September 27th Merger anticipated to close September 29 th with NASDAQ trading to begin October 2 nd under the ticker symbol COCH White Bear Lake, Minnesota--(Newsfile Corp. - September 28, 2023) - Envoy Medical® Corporation ("Envoy"), a hearing health company, today announced that the proposed merger with Anzu Special Acquisition Corp I (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) ("Anzu") was approved by a vote of Envoy Medical shareholders in a special meeting held September 28, 2023. The vote follows the announcement of approval by Anzu shareholders on September 27, 2023.
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
newsfilecorp.com
2023-09-19 16:05:00Board Reflects Expanded Resources as Company Readies for Nasdaq Listing White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2023) - Envoy Medical® Corporation ("Envoy"), a hearing health company, today announced the proposed slate of seven directors to be voted on during the special meeting of stockholders to be held by its merger partner, Anzu Special Acquisition Corp (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) ("Anzu"), which is expected to be held on September 27, 2023. The director nominees bring medical device industry, financial and equity capital markets expertise, including alumni of Abbott, Medtronic, Boston Scientific, Johnson & Johnson, PwC, and BCG.
Envoy Medical Appoints David R. Wells as Chief Financial Officer
newsfilecorp.com
2023-08-24 16:05:00Adds Experienced Financial and Equity Capital Markets Leader as Company Readies for Nasdaq Listing White Bear Lake, Minnesota--(Newsfile Corp. - August 24, 2023) - Envoy Medical® Corporation, a hearing health company, today announced the appointment of industry veteran David R. Wells as Chief Financial Officer.
CORRECTING and REPLACING Anzu Special Acquisition Corp I Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing April 22, 2021
businesswire.com
2021-04-21 22:51:00TAMPA, Fla.--(BUSINESS WIRE)---- $ANZU--First paragraph, first sentence of release should read: April 22, 2021 (instead of April 22, 2020). The updated release reads: ANZU SPECIAL ACQUISITION CORP I ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A COMMON STOCK AND WARRANTS, COMMENCING APRIL 22, 2021 Anzu Special Acquisition Corp I (NASDAQ: ANZUU) (the “Company”), a blank check company sponsored by Anzu SPAC GP I LLC, today announced that the holders of the Company's units sold in the Company's initial publi